Image de couverture de livre

Epidemiology of hepatocellular carcinoma

Fuente: Redalyc

Enregistré dans:

Détails bibliographiques
Auteur principal:	RAYMUNDO PARANÁ
Format:	Artículo científico
Langue:	en
Publié:	Universidad de Antioquia 2007
Sujets:	Medicina
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Análise radiográfica do preenchimento de canais laterais por quatro diferentes técnicas de obturação
par: Andressa RAYMUNDO
Publié: (2005)

Methylation in hepatocellular carcinoma
par: REGINA M. SANTELLA
Publié: (2007)

Clinical and laboratory features of hepatocellular carcinoma
par: MARIA C. LONDOÑO
Publié: (2007)

Hepatitis infections, aflatoxin and hepatocellular carcinoma
par: PIERRE HAINAUT
Publié: (2007)

Immunosupression in liver transplant for hepatocellular carcinoma
par: JUAN-CARLOS RESTREPO
Publié: (2007)

Proteomics for the early diagnosis and treatment of hepatocellular carcinoma
par: VIJAY KUMAR
Publié: (2007)

LA PRENSA MEXICANA, ¿CONTROLADA?
par: RIVA PALACIOS, RAYMUNDO
Publié: (1992)

Hepatoid adenocarcinoma of the lung mimicking metastatic hepatocellular carcinoma
par: Yu Miyama
Publié: (2020)

Etiology of hepatocellular carcinoma in Argentina: results of a multicenter retrospective study
par: Eduardo Fassio
Publié: (2009)

Efecto del DHA sobre la expresión de la Δ6-desaturasa durante el desarrollo larvario del pargo amarillo, Lutjanus argentiventris
par: BIVIANA ISABEL PAZ RAYMUNDO
Publié: (2014)

MRI for hepatocellular carcinoma and the role of abbreviated MRI for surveillance of hepatocellular carcinoma
par: Soe Thiha Maung, et autres
Publié: (2024)

Sorafenib for recurrent hepatocellular carcinoma after liver transplantation: a South American experience
par: Federico Piñero
Publié: (2016)

Delta virus infection and hepatocellular carcinoma
par: Maurizio Bonacini
Publié: (2024)

Intrahepatic splenosis mimicking hepatocellular carcinoma
par: Martina Rosi, et autres
Publié: (2024)

Systemic therapies in hepatocellular carcinoma: A revolution?
par: Marta Fortuny, et autres
Publié: (2024)

Sister Mary Joseph's nodule in hepatocellular carcinoma
par: Arpit Shastri, et autres
Publié: (2024)

Emerging nanomedicine strategies for hepatocellular carcinoma therapy
par: Chen Guo, et autres
Publié: (2024)

Opportunities to improve surveillance of hepatocellular carcinoma in Australia
par: Jess Howell, et autres
Publié: (2025)

Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma
par: Hidenori Toyoda, et autres
Publié: (2024)

Whole‐exome sequencing‐based mutational profiling of hepatocellular adenoma malignant transformation to hepatocellular carcinoma
par: Yichao Bu, et autres
Publié: (2024)

Epidemiology of cancer in Colombia
par: Luis Eduardo Bravo
Publié: (2018)

Clinical outcomes of hepatocellular carcinoma surveillance in Melbourne, Australia
par: Samuel Hui, et autres
Publié: (2024)

The cumulative antitumor effects of regorafenib and radiotherapy in hepatocellular carcinoma
par: Shuwen Kuang, et autres
Publié: (2024)

Genetic variants underlying precancerous conditions of hepatocellular carcinoma
par: Jonathan Jaime G. Guerrero, et autres
Publié: (2025)

A classification model for resectability in hepatocellular carcinoma patients
par: Ikuo Nakamura, et autres
Publié: (2024)

Olsalazine pretreatment augments chemosensitivity of gemcitabine in hepatocellular carcinoma
par: Ayush Sharma, et autres
Publié: (2024)

Alcohol and smoking habits in association with hepatocellular carcinoma risk
par: Elom K. Aglago, et autres
Publié: (2025)

An Epidemiology to Give Visibility to the Invisible
par: GIANNI TOGNONI
Publié: (2015)

Perfusion of hepatocellular carcinomas measured by diffusion‐derived vessel density biomarker: Higher hepatocellular carcinoma perfusion than earlier intravoxel incoherent motion reports
par: Xin‐Ming Li, et autres
Publié: (2024)

The landscape of etiological patterns of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in Thailand
par: Benjarath Pupacdi, et autres
Publié: (2024)

Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives
par: Jian‐Jian Chen, et autres
Publié: (2024)

Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy
par: Yongqing Qin, et autres
Publié: (2024)

Prognostic biomarkers associated with immune checkpoint inhibitors in hepatocellular carcinoma
par: Xiu Chen, et autres
Publié: (2024)

Metastatic hepatocellular carcinoma presenting as a lytic calvarial mass
par: Shirley Parraga, et autres
Publié: (2024)

NK cell‐based immunotherapy for hepatocellular carcinoma: Challenges and opportunities
par: Pei Guo, et autres
Publié: (2025)

Aberrant TERT expression: linking chronic inflammation to hepatocellular carcinoma†
par: Rui Dong, et autres
Publié: (2025)

Cabozantinib as the first step toward postimmunotherapy treatment in hepatocellular carcinoma
par: Bo Pei, et autres
Publié: (2024)

The combination of midkine inhibitor with Lenvatinib amplifies the suppression of hepatocellular carcinoma
par: Xue Chen, et autres
Publié: (2025)

Circular RNA‐based neoantigen vaccine for hepatocellular carcinoma immunotherapy
par: Fei Wang, et autres
Publié: (2024)

LC–MS/MS method for the quantification of cortisol of hepatocellular carcinoma
par: Zijing Zhou, et autres
Publié: (2024)